Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Patrice Wendling

  • 1
    News

    Ivabradine knocks down heart rate, symptoms in POTS

    February 19, 2021

    The heart failure drug also may be helpful in treating similar symptoms in patients with long-hauler COVID-19, researchers say.

  • 1
    News

    More Americans hospitalized, readmitted for heart failure

    February 16, 2021

    “We should be emphasizing the things we know work to reduce heart failure hospitalization, which is, number one, prevention.”

  • 1
    News

    ColCORONA: More questions than answers for colchicine in COVID-19

    February 11, 2021

    Millions of dollars and thousands of patients later, the phase 3 study highlights the challenges of COVID-19–related preprint studies without peer review.

  • News

    Cardiac activity not uncommon after lifesaving measures stop

    February 5, 2021

    ECG and blood pressure monitoring identified resumption of cardiac activity in 14% of patients, all occurring in the 5 minutes after pulselessness.

  • News

    ColCORONA: Colchicine reduces complications in outpatient COVID-19

    January 25, 2021

    The use of colchicine was reported to significantly reduce hospitalizations, the need for mechanical ventilation, and deaths.

  • News

    Full-dose anticoagulation reduces need for life support in COVID-19

    January 25, 2021

    “We have treatments that are improving outcomes but not as many that reduce mortality, so we’re hopeful when the full dataset comes in that will be confirmed.”

  • News

    Fracking sites tied to increased heart failure hospitalizations

    December 10, 2020

    The results were consistent and robust among more than 9,000 patients with heart failure in Pennsylvania, a state steeped in controversy over fracking.

  • 1
    News

    Intravenous iron reduces HF readmissions: AFFIRM-AHF

    November 14, 2020

    The results are likely to change heart failure guidelines, which currently give a lukewarm recommendation for intravenous iron in the US, experts say.

  • News

    HF an added risk in COVID-19, regardless of ejection fraction

    November 3, 2020

    A history of HF was associated with a near doubling risk of in-hospital mortality and ICU care.

  • 1
    News

    NACMI: Clear benefit with PCI in STEMI COVID-19 patients

    October 16, 2020

    Angiography fell off but door-to-balloon times haven’t suffered, even with the pandemic, according to initial results from the North American registry.

Previous1 2 3Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences